SNS Financial Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.03M | Buy |
2,842
+1,183
| +71% | +$405K | 0.02% | 295 |
|
|
2026
Q1 | $584K | Sell |
1,659
-36
| -2% | -$12.8K | 0.05% | 116 |
|
|
2025
Q4 | $555K | Sell |
1,695
-53
| -3% | -$16.8K | 0.05% | 113 |
|
|
2025
Q3 | $493K | Sell |
1,748
-59
| -3% | -$17.1K | 0.04% | 121 |
|
|
2025
Q2 | $505K | Sell |
1,807
-1,728
| -49% | -$490K | 0.05% | 114 |
|
|
2025
Q1 | $1.1M | Sell |
3,535
-1,677
| -32% | -$495K | 0.11% | 80 |
|
|
2024
Q4 | $1.36M | Sell |
5,212
-475
| -8% | -$141K | 0.14% | 68 |
|
|
2024
Q3 | $1.83M | Sell |
5,687
-214
| -4% | -$70K | 0.18% | 55 |
|
|
2024
Q2 | $1.84M | Sell |
5,901
-249
| -4% | -$73.2K | 0.2% | 52 |
|
|
2024
Q1 | $1.75M | Sell |
6,150
-111
| -2% | -$32.5K | 0.19% | 53 |
|
|
2023
Q4 | $1.8M | Sell |
6,261
-592
| -9% | -$161K | 0.21% | 52 |
|
|
2023
Q3 | $1.84M | Sell |
6,853
-282
| -4% | -$70.4K | 0.24% | 49 |
|
|
2023
Q2 | $1.58M | Sell |
7,135
-61
| -0.8% | -$14.2K | 0.21% | 56 |
|
|
2023
Q1 | $1.74M | Buy |
7,196
+136
| +2% | +$33.4K | 0.23% | 57 |
|
|
2022
Q4 | $1.85M | Buy |
7,060
+47
| +0.7% | +$12.6K | 0.25% | 53 |
|
|
2022
Q3 | $1.58M | Buy |
7,013
+15
| +0.2% | +$3.64K | 0.23% | 60 |
|
|
2022
Q2 | $1.7M | Buy |
6,998
+118
| +2% | +$28.9K | 0.22% | 60 |
|
|
2022
Q1 | $1.66M | Sell |
6,880
-145
| -2% | -$33.3K | 0.18% | 72 |
|
|
2021
Q4 | $1.58M | Sell |
7,025
-244
| -3% | -$51.5K | 0.17% | 79 |
|
|
2021
Q3 | $1.55M | Sell |
7,269
-1,306
| -15% | -$301K | 0.19% | 74 |
|
|
2021
Q2 | $2.09M | Buy |
8,575
+1,826
| +27% | +$449K | 0.27% | 56 |
|
|
2021
Q1 | $1.68M | Buy |
6,749
+120
| +2% | +$28.6K | 0.22% | 65 |
|
|
2020
Q4 | $1.52M | Sell |
6,629
-348
| -5% | -$80.2K | 0.22% | 66 |
|
|
2020
Q3 | $1.77M | Sell |
6,977
-138
| -2% | -$34.2K | 0.28% | 51 |
|
|
2020
Q2 | $1.68M | Sell |
7,115
-78
| -1% | -$17.8K | 0.3% | 52 |
|
|
2020
Q1 | $1.46M | Sell |
7,193
-267
| -4% | -$58.3K | 0.28% | 67 |
|
|
2019
Q4 | $1.8M | Sell |
7,460
-323
| -4% | -$71.2K | 0.32% | 55 |
|
|
2019
Q3 | $1.51M | Sell |
7,783
-36
| -0.5% | -$6.91K | 0.29% | 57 |
|
|
2019
Q2 | $1.44M | Sell |
7,819
-288
| -4% | -$51.6K | 0.27% | 60 |
|
|
2019
Q1 | $1.54M | Sell |
8,107
-135
| -2% | -$25.8K | 0.34% | 55 |
|
|
2018
Q4 | $1.6M | Sell |
8,242
-335
| -4% | -$65.4K | 0.4% | 52 |
|
|
2018
Q3 | $1.78M | Sell |
8,577
-323
| -4% | -$63.7K | 0.43% | 50 |
|
|
2018
Q2 | $1.64M | Sell |
8,900
-432
| -5% | -$76.4K | 0.43% | 47 |
|
|
2018
Q1 | $1.59M | Sell |
9,332
-517
| -5% | -$94.9K | 0.43% | 47 |
|
|
2017
Q4 | $1.71M | Sell |
9,849
-246
| -2% | -$43.5K | 0.41% | 53 |
|
|
2017
Q3 | $1.88M | Sell |
10,095
-822
| -8% | -$146K | 0.48% | 50 |
|
|
2017
Q2 | $1.88M | Sell |
10,917
-1,510
| -12% | -$246K | 0.5% | 48 |
|
|
2017
Q1 | $2.04M | Sell |
12,427
-3,419
| -22% | -$568K | 0.52% | 48 |
|
|
2016
Q4 | $2.32M | Buy |
15,846
+1,781
| +13% | +$268K | 0.68% | 39 |
|
|
2016
Q3 | $2.35M | Buy |
14,065
+3,647
| +35% | +$617K | 0.68% | 31 |
|
|
2016
Q2 | $1.58M | Buy |
+10,418
| New | +$1.62M | 0.4% | 49 |
|
Other funds holding AMGN
SNS Financial Group's AMGN Position: Q2 2026 in Review
SNS Financial Group increased its Amgen (AMGN) stake by 71% in Q2 2026, buying an estimated $405K and bringing the position to 2,842 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #295.
SNS Financial Group first reported a position in AMGN in Q2 2016 and has held it in 41 quarters since. The position peaked at $2.35M in Q3 2016. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- SNS Financial Group held 2,842 shares of Amgen worth $1.03M as of Q2 2026.
- SNS Financial Group bought 1,183 Amgen shares in Q2 2026, an estimated $405K.
- Amgen made up 0.02% of SNS Financial Group's portfolio in Q2 2026, its #295 holding.
- SNS Financial Group first reported a position in Amgen in Q2 2016 and has held it in 41 quarters since.
- SNS Financial Group's Amgen position peaked at $2.35M in Q3 2016.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on SNS Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.